Table 4 |
||||
|
Logistic regression model exploring association between baseline anti-CCP titer and radiographic and functional outcome at 5 years |
||||
|
5-year outcome |
OR (95% CI) |
P |
Adjusted ORa |
Adjusted Pa |
|
|
||||
|
Erosions |
1.03 (1.02, 1.04) |
< 0.0001 |
1.03 (1.01, 1.03) |
< 0.0001 |
|
Larsen score > 15 |
1.03 (1.02, 1.03) |
< 0.0001 |
1.02 (1.01, 1.03) |
< 0.0001 |
|
HAQ ≥ 1 |
1.01 (1.01, 1.02) |
< 0.0001 |
1.00 (0.99, 1.01) |
0.47 |
|
|
||||
|
aAdjusted for age, gender, symptom duration and CRP, RF, HAQ, and swollen- and tender-joint counts at baseline. OR, odds ratio; CI, confidence interval. Baseline anti-CCP titer was available in 596 patients. ACR, American College of Rheumatology criteria for rheumatoid arthritis; DAS, disease activity score; HAQ, Health Assessment Questionnaire. |
||||
|
Burr et al. Arthritis Research & Therapy 2012 14:R109 doi:10.1186/ar3834 |
||||